Suppr超能文献

中国衢州采用 Cox 比例风险模型将含腮腺炎两剂疫苗纳入常规免疫接种计划。

Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model.

机构信息

Quzhou Center for Disease Control and Prevention, Quzhou, 324000 Zhejiang, China.

Quzhou Women & Children's Hospital, Quzhou, 324000 Zhejiang, China.

出版信息

J Immunol Res. 2021 Nov 5;2021:5990417. doi: 10.1155/2021/5990417. eCollection 2021.

Abstract

Mumps is a vaccine-preventable disease caused by the mumps virus, but the incidence of mumps has increased among the children who were vaccinated with one-dose measles-mumps-rubella (MMR) in recent years. In this study, we analyzed the influence of different doses of mumps-containing vaccine (MuCV) against mumps using Cox-proportional hazard model. We collected 909 mumps cases of children who were born from 2006 to 2010 and vaccinated with different doses of MuCV in Quzhou during 2006-2018, which were all clinically diagnosed. Kaplan-Meier survival methods and Cox-proportional hazard model were used to estimate the hazard probabilities. Kaplan-Meier curves showed that the cumulative hazard of male and female has no difference; lower hazards were detected among those who were vaccinated with two-dose MuCV, born in 2006, and infected after supplementary immunization activities (SIA). Cox-proportional hazard regression suggested that onset after SIA, born in 2006, and vaccinated with two-dose MuCV were protective factors against infection even after adjusting for potential confounding effects. Our study showed that it was necessary to revise the diagnostic criteria of mumps and identify RT-PCR as the standard for mumps diagnosis in China. We suggested that routine immunization schedule should introduce two doses of MMR and prevaccination screening should be performed before booster immunization in vaccinated populations.

摘要

流行性腮腺炎是由腮腺炎病毒引起的可通过疫苗预防的疾病,但近年来,在接种一剂麻疹-腮腺炎-风疹(MMR)疫苗的儿童中,流行性腮腺炎的发病率有所上升。在这项研究中,我们使用 Cox 比例风险模型分析了不同剂量腮腺炎疫苗(MuCV)对流行性腮腺炎的影响。我们收集了 2006 年至 2010 年在衢州出生且于 2006 年至 2018 年期间接种过不同剂量 MuCV 的 909 例流行性腮腺炎患儿的病例,这些患儿均经临床诊断。使用 Kaplan-Meier 生存方法和 Cox 比例风险模型来估计风险概率。Kaplan-Meier 曲线显示,男性和女性的累积风险无差异;接种两剂 MuCV、2006 年出生且在补充免疫活动(SIA)后感染的儿童风险较低。Cox 比例风险回归表明,SIA 后发病、2006 年出生且接种两剂 MuCV 是感染的保护因素,即使在调整了潜在混杂因素的影响后也是如此。我们的研究表明,有必要修改腮腺炎的诊断标准,并在中国将 RT-PCR 确定为腮腺炎诊断的标准。我们建议常规免疫接种方案应引入两剂 MMR,在加强免疫接种前应对接种人群进行预接种筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c1/8589524/03df7e48e051/JIR2021-5990417.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验